Innovative cancer cell therapy project lands €2.5 million EIC funding
Asgard Therapeutics, in partnership with Lund University and Herlev Hospital, has been awarded €2.5 million for an EIC Transition project from the European Innovation Council. EIC Transition is a funding program under Horizon Europe aimed at validating and demonstrating a specific technology in a relevant environment while also developing business and market readiness.The project is coordinated by
https://www.stemcellcenter.lu.se/article/innovative-cancer-cell-therapy-project-lands-eu25-million-eic-funding - 2025-10-01